• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白细胞介素-33与肾脏疾病(综述)

IL‑33 and kidney disease (Review).

作者信息

Yang Feifei, Zhu Ping, Duan Lihua, Yang Lin, Wang Jiajun

机构信息

Department of Nephrology, The First College of Clinical Medical Science, Three Gorges University, Yichang, Hubei 443003, P.R. China.

Department of Rheumatology and Clinical Immunology, The First Hospital of Xiamen University, Xiamen, Fujian 361000, P.R. China.

出版信息

Mol Med Rep. 2016 Jan;13(1):3-8. doi: 10.3892/mmr.2015.4516. Epub 2015 Nov 6.

DOI:10.3892/mmr.2015.4516
PMID:26548720
Abstract

Interleukin (IL)-33, is a novel member of the IL-1 superfamily, and act as a dual-function molecule as a nuclear factor and cytokine. The expression of IL-33 can be detected in several tissues and cells in humans and in mice. In addition to the conventional secretion approach for cytokines, full-length IL-33 can also be released into the extracellular space following cell damage or mechanical injury. IL-33 mediates its biological effects by interacting with the receptors, suppression of tumorigenicity 2 (ST2) and IL-1 receptor accessory protein, activating intracellular molecules in the nuclear factor-κB and mitogen-activated protein kinase signaling pathways, which drive the production of type 2 cytokines, including IL-4, IL-5 and IL-3, from polarized T helper 2 cells. Increasing evidence indicates that IL-33 is important in chronic kidney disease, and may be involved in the progression of renal fibrosis associated with systemic lupus erythematosus and renal graft damage. In addition, IL-33 contributes to acute kidney injury. In the present review, the biology of IL-33, and the association of IL-33 with kidney diseases are discussed.

摘要

白细胞介素(IL)-33是IL-1超家族的一个新成员,作为一种核因子和细胞因子发挥双重功能分子的作用。在人和小鼠的多种组织和细胞中均可检测到IL-33的表达。除了细胞因子的传统分泌方式外,全长IL-33在细胞损伤或机械损伤后也可释放到细胞外空间。IL-33通过与受体、抑瘤2(ST2)和IL-1受体辅助蛋白相互作用来介导其生物学效应,激活核因子-κB和丝裂原活化蛋白激酶信号通路中的细胞内分子,从而驱动极化的辅助性T细胞2产生2型细胞因子,包括IL-4、IL-5和IL-3。越来越多的证据表明,IL-33在慢性肾脏病中起重要作用,可能参与系统性红斑狼疮相关的肾纤维化进展和肾移植损伤。此外,IL-33还与急性肾损伤有关。在本综述中,将讨论IL-33的生物学特性以及IL-33与肾脏疾病的关联。

相似文献

1
IL‑33 and kidney disease (Review).白细胞介素-33与肾脏疾病(综述)
Mol Med Rep. 2016 Jan;13(1):3-8. doi: 10.3892/mmr.2015.4516. Epub 2015 Nov 6.
2
Emerging Roles of IL-33/ST2 Axis in Renal Diseases.白细胞介素-33/ST2轴在肾脏疾病中的新作用
Int J Mol Sci. 2017 Apr 7;18(4):783. doi: 10.3390/ijms18040783.
3
Interleukin 33 is a guardian of barriers and a local alarmin.白细胞介素 33 是屏障的守护者和局部警报素。
Nat Immunol. 2016 Feb;17(2):122-31. doi: 10.1038/ni.3370.
4
Intracellular JNK, p38 MAPK and NF-kappaB regulate IL-25 induced release of cytokines and chemokines from costimulated T helper lymphocytes.细胞内的JNK、p38丝裂原活化蛋白激酶(MAPK)和核因子κB(NF-κB)调节白细胞介素-25(IL-25)诱导共刺激T辅助淋巴细胞释放细胞因子和趋化因子。
Immunol Lett. 2007 Oct 15;112(2):82-91. doi: 10.1016/j.imlet.2007.07.002. Epub 2007 Aug 1.
5
IL-33/ST2 Pathway as a Rational Therapeutic Target for CNS Diseases.IL-33/ST2 通路作为中枢神经系统疾病的合理治疗靶点。
Neuroscience. 2018 Jan 15;369:222-230. doi: 10.1016/j.neuroscience.2017.11.028. Epub 2017 Nov 24.
6
The Role of IL-33/ST2 Pathway in Tumorigenesis.IL-33/ST2 通路在肿瘤发生中的作用。
Int J Mol Sci. 2018 Sep 9;19(9):2676. doi: 10.3390/ijms19092676.
7
Interleukin-18.白细胞介素-18
Methods. 1999 Sep;19(1):121-32. doi: 10.1006/meth.1999.0837.
8
Interleukin-33 in Systemic Sclerosis: Expression and Pathogenesis.白细胞介素-33 在系统性硬化症中的表达和发病机制。
Front Immunol. 2018 Nov 15;9:2663. doi: 10.3389/fimmu.2018.02663. eCollection 2018.
9
The Functional Roles of IL-33/ST2 Axis in Ocular Diseases.IL-33/ST2 轴在眼部疾病中的功能作用。
Mediators Inflamm. 2020 Aug 18;2020:5230716. doi: 10.1155/2020/5230716. eCollection 2020.
10
IL-33: a potential therapeutic target in autoimmune diseases.IL-33:自身免疫性疾病的潜在治疗靶点。
J Investig Med. 2012 Dec;60(8):1151-6. doi: 10.2310/JIM.0b013e31826d8fcb.

引用本文的文献

1
Mechanisms Underlying the Impact of Interleukin Family on Acute Kidney Injury: Pathogenesis, Progression, and Therapy.白细胞介素家族对急性肾损伤影响的潜在机制:发病机制、进展及治疗
Research (Wash D C). 2025 Jun 13;8:0738. doi: 10.34133/research.0738. eCollection 2025.
2
Partial reduction of interleukin-33 signaling improves senescence and renal injury in diabetic nephropathy.白细胞介素-33信号通路的部分抑制可改善糖尿病肾病中的衰老和肾损伤。
MedComm (2020). 2024 Oct 24;5(11):e742. doi: 10.1002/mco2.742. eCollection 2024 Nov.
3
Immune-Modulating Effects of Low-Carbohydrate Ketogenic Foods in Healthy Canines.
低碳水化合物生酮饮食对健康犬类的免疫调节作用
Curr Dev Nutr. 2024 Feb 28;8(4):102128. doi: 10.1016/j.cdnut.2024.102128. eCollection 2024 Apr.
4
Knowledge mapping of interleukin-33: a bibliometric study.白细胞介素-33的知识图谱:一项文献计量学研究
Am J Transl Res. 2023 Feb 15;15(2):914-931. eCollection 2023.
5
Interleukin-33/ Suppression of Tumorigenicity 2 in Renal Fibrosis: Emerging Roles in Prognosis and Treatment.白细胞介素-33/肿瘤抑制因子2在肾纤维化中的作用:在预后和治疗中的新作用
Front Physiol. 2022 Jan 3;12:792897. doi: 10.3389/fphys.2021.792897. eCollection 2021.
6
Inflammatory response and matrix metalloproteinases in chronic kidney failure: Modulation by adropin and spexin.慢性肾衰竭中的炎症反应和基质金属蛋白酶:阿多品和瘦素的调节作用。
Exp Biol Med (Maywood). 2021 Sep;246(17):1917-1927. doi: 10.1177/15353702211012417. Epub 2021 May 22.
7
Kidney GATA3 regulatory T cells play roles in the convalescence stage after antibody-mediated renal injury.肾脏 GATA3 调节性 T 细胞在抗体介导的肾损伤后恢复期发挥作用。
Cell Mol Immunol. 2021 May;18(5):1249-1261. doi: 10.1038/s41423-020-00547-x. Epub 2020 Sep 11.
8
IL33/ST2 Axis in Diabetic Kidney Disease: A Literature Review.糖尿病肾病中的白细胞介素33/ST2轴:文献综述
Medicina (Kaunas). 2019 Feb 14;55(2):50. doi: 10.3390/medicina55020050.
9
IL-33/ST2 axis mediates hyperplasia of intrarenal urothelium in obstructive renal injury.IL-33/ST2 轴介导梗阻性肾损伤中肾内尿路上皮的增生。
Exp Mol Med. 2018 Apr 20;50(4):1-11. doi: 10.1038/s12276-018-0047-8.
10
IL-33 deficiency slows cancer growth but does not protect against cisplatin-induced AKI in mice with cancer.IL-33 缺乏会减缓癌症的生长,但不能预防癌症小鼠顺铂诱导的 AKI。
Am J Physiol Renal Physiol. 2018 Mar 1;314(3):F356-F366. doi: 10.1152/ajprenal.00040.2017. Epub 2017 Oct 25.